InsidersTradesSigma
Follow the Brii Biosciences Ltd. - B share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on the HK market, under the oversight of HKEX. Market capitalisation: €67.2m. The latest transaction was filed on 31 August 2026 (Sale). Among the most active insiders: Li Ankang. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Brii Biosciences Ltd. - B is a biopharmaceutical company focused on developing innovative treatments for infectious diseases and public health-related disorders. It is committed to improving patient lives through advanced therapeutic solutions.